Abstract
Luspatercept (REBLOZYL (R)) is an erythroid maturation agent developed by Acceleron Pharma and Celgene Corporation for the treatment of anaemia associ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
